Malaria pills span several different drugs, and each one carries its own profile of side effects. The most commonly prescribed preventive options for travelers include doxycycline, mefloquine, atovaquone-proguanil (Malarone), chloroquine, and primaquine, while treatment drugs include artemisinin-based combinations and quinine. Mild stomach upset is the shared complaint across nearly all of them, but the more distinctive risks range from sun sensitivity and esophageal damage with doxycycline to psychiatric symptoms with mefloquine and dangerous blood breakdown in people with a specific enzyme deficiency taking primaquine. Understanding which drug you are taking, and what it can do, matters far more than worrying about “malaria pills” as a single category.
Stomach Problems Are the Baseline
Almost every antimalarial can cause nausea, vomiting, diarrhea, or abdominal discomfort. A large Cochrane review comparing mefloquine to doxycycline found that mefloquine users were more likely to report nausea, while doxycycline users had higher rates of vomiting (about 5% versus 1% for mefloquine) and dyspepsia (about 14% versus 4% for mefloquine).1PubMed Central. Mefloquine for preventing malaria during travel to endemic areas Atovaquone-proguanil tends to sit in the middle: it can cause nausea and occasional stomach pain, but most people tolerate it reasonably well. Proguanil on its own has been linked to nausea in roughly 13 out of every 100 users in one comparative study.2PubMed. Adverse effects and compliance with mefloquine or proguanil antimalarial chemoprophylaxis
These gut symptoms are usually mild and tend to settle down after the first week or two. Taking the pills with food and plenty of water helps. For most travelers, these complaints are an annoyance rather than a reason to stop the medication, though some people do switch drugs if nausea persists.
Doxycycline and Sun Sensitivity
Doxycycline is one of the most widely prescribed malaria prevention pills, partly because it is cheap and effective in areas where other drugs face resistance. Its signature side effect is photosensitivity: a heightened reaction to sunlight that can range from a mild sunburn-like sensation to severe, widespread skin inflammation. A systematic review found that the triggering wavelength is primarily UVA1 (340 to 400 nm), which means standard sunscreens that only block UVB are not enough. You need a broad-spectrum product that specifically covers UVA.3PubMed. Phototoxicity of Doxycycline: A Systematic Review on Clinical Manifestations, Frequency, Cofactors, and Prevention The same review noted that nail loosening, where the nail lifts off the nail bed, can also occur from doxycycline-related sun exposure.
This is worth taking seriously if you are heading to a sunny tropical destination, which is exactly where malaria risk tends to be highest. Covering up during peak sun hours and applying UVA-blocking sunscreen is not optional on doxycycline; it is the difference between a normal trip and a miserable skin reaction.
Doxycycline and Your Esophagus
A less well-known but entirely preventable problem with doxycycline is esophageal ulceration. Doxycycline is a relatively large pill with a very low pH, and if it gets stuck in the esophagus, it can cause a chemical burn to the lining. Case reports have documented ulceration after just a single dose taken improperly.4PubMed Central. Esophageal Ulceration Following the Ingestion of a Single Dose of Doxycycline: A Case Report The capsule form is particularly risky because it can remain in the esophagus three times longer than the tablet form.
The pattern across case series is consistent: patients swallowed the capsule with too little water or took it right before lying down.5PubMed. Doxycycline-induced pill esophagitis The resulting symptoms include painful swallowing, a burning sensation behind the breastbone, and difficulty getting food down. Endoscopy typically shows an ulcer in the middle third of the esophagus, right where the aorta presses against it and creates a natural bottleneck.6PubMed Central. Oesophageal ulceration in adult patients treated with doxycycline for acne vulgaris
The fix is simple: take doxycycline with a full glass of water, remain upright for at least 30 minutes afterward, and avoid taking it right before bed. If your doctor prescribes the capsule form, ask whether a tablet is available instead.
Mefloquine and Psychiatric Side Effects
Mefloquine (Lariam) has the most contentious reputation among malaria prophylaxis drugs, and for good reason. While many users have no trouble with it, a meaningful minority experience neuropsychiatric effects that go well beyond ordinary side effects. Depression, dizziness, and vivid or disturbing dreams are the commonly reported problems. One comparative study found excess risk rates of about 7 per 100 users for depression and about 9 per 100 for dizziness.2PubMed. Adverse effects and compliance with mefloquine or proguanil antimalarial chemoprophylaxis
At the severe end, mefloquine can provoke psychotic symptoms. A follow-up study of Danish adverse event reports found that about 15% of people who reported psychiatric side effects experienced substantial psychotic symptoms during the acute phase, including hallucinations that were more frequently observed among women.7PubMed. Acute and long-term psychiatric side effects of mefloquine: a follow-up on Danish adverse event reports These were generally time-limited, resolving after the drug was stopped. But that is little comfort to someone experiencing hallucinations on a vacation.
The U.S. FDA added a boxed warning to mefloquine in 2013 noting that neurological side effects can persist or become permanent in rare cases. People with a history of depression, anxiety, psychosis, or seizures are generally steered away from mefloquine entirely. A long-term study of Peace Corps Volunteers confirmed that avoiding mefloquine in people with prior psychiatric illness substantially reduces the risk of psychiatric side effects.8PubMed Central. Long term health outcomes among Returned Peace Corps Volunteers after malaria prophylaxis, 1995-2014
Chloroquine and Hydroxychloroquine
Chloroquine was once the default malaria pill, but widespread parasite resistance has limited it to a shrinking number of regions. Where it is still used, its common side effects include headache, dizziness, vomiting, and diarrhea. More concerning are its neuropsychiatric effects: chloroquine and hydroxychloroquine can cross the blood-brain barrier and reach concentrations in the brain many times higher than in the bloodstream, which can trigger behavioral changes, anxiety, depression, and in rare cases acute psychosis.9PubMed Central. Chloroquine-Induced Psychosis: A Case Report Case reports document psychosis developing even at the standard prophylactic dose of 500 mg per week.10General Hospital Psychiatry. Psychosis following chloroquine ingestion: a 10-year comparative study from a malaria-hyperendemic district of India
Hydroxychloroquine, used more often today for autoimmune conditions than for malaria, carries a well-documented risk of retinal toxicity with long-term use. The damage is dose-dependent and, critically, irreversible once it sets in. Early screening with eye exams is essential for anyone on the drug for extended periods.11PubMed Central. Target in Sight: A Comprehensive Review of Hydroxychloroquine-Induced Bull’s Eye Maculopathy This retinal risk is less relevant for the short courses used in malaria prophylaxis, but it becomes a real concern for travelers or expatriates taking chloroquine-class drugs over months or years.
Primaquine, Tafenoquine, and the Risk of Hemolysis
Primaquine and the newer tafenoquine belong to the 8-aminoquinoline class and are the only drugs that can eliminate the dormant liver-stage parasites responsible for malaria relapses. They are also the malaria drugs most capable of causing serious harm in a specific group of people: those with glucose-6-phosphate dehydrogenase (G6PD) deficiency, an inherited enzyme shortage affecting hundreds of millions of people worldwide, particularly in malaria-endemic regions of Africa, the Mediterranean, and Southeast Asia.
In someone with G6PD deficiency, primaquine triggers the destruction of red blood cells, a process called hemolytic anemia. The severity depends on the dose and on how much enzyme activity the person retains.12PubMed Central. Modelling primaquine-induced haemolysis in G6PD deficiency Tafenoquine carries the same risk. In a clinical study of women who were heterozygous carriers of a G6PD-deficient variant, a single 300 mg dose of tafenoquine caused hemoglobin drops of roughly 2.7 to 3.0 g/dL, and the response was worse in those with lower baseline enzyme activity.13PubMed Central. Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers
Because of this, G6PD testing is required before prescribing either primaquine or tafenoquine. The test is a simple blood draw, and skipping it is genuinely dangerous. Tafenoquine has a longer half-life than primaquine, meaning that once it is in your body, you cannot simply stop it if hemolysis begins. This is why screening is non-negotiable with these drugs.
Delayed Hemolysis After Artesunate
Artemisinin-based drugs are the backbone of malaria treatment worldwide, and intravenous artesunate is the standard of care for severe malaria. These drugs are generally well tolerated during treatment, but a distinctive delayed side effect can appear one to three weeks after the first dose: post-artesunate delayed hemolysis (PADH).
The leading explanation is a process called “pitting.” Artesunate rapidly kills parasites inside red blood cells, and the spleen then strips out the dead parasites, sending the now-empty red blood cells back into circulation. These pitted cells are smaller and structurally compromised, and they have a shortened lifespan of roughly 7 to 21 days. When they break down en masse, the result is a wave of hemolytic anemia that shows up well after treatment seemed successful.14PubMed Central. Post-Artesunate Delayed Hemolysis: A Review of Current Evidence Patients typically present with dropping hemoglobin levels and rising markers of red blood cell destruction about a week or more after starting artesunate.15PubMed Central. Delayed Hemolysis With Parenteral Artesunate
PADH is more common in people who had high initial parasite loads, which makes sense given that more parasitized cells means more pitted cells re-entering circulation. It is generally manageable with monitoring and occasionally requires blood transfusion, but anyone treated with artesunate for severe malaria needs follow-up blood work for several weeks afterward.16Clinical Infectious Diseases. Post-artesunate Delayed Hemolysis in Patients With Severe Malaria in the United States—April 2019 Through July 2021
Heart Rhythm Changes
Several antimalarials can affect the electrical activity of the heart, specifically by prolonging the QT interval, the time it takes for the heart’s ventricles to reset between beats. An excessively prolonged QT interval raises the risk of a dangerous arrhythmia called Torsade de Pointes. A systematic review found that quinoline-class antimalarials are broadly associated with this effect, though the degree varies enormously between drugs.17PubMed Central. The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review
Among the drugs used to treat malaria (as opposed to prevent it), halofantrine carries the highest cardiac risk and is rarely used today for that reason. Among artemisinin-based combination therapies, a study evaluating four common regimens found that dihydroartemisinin-piperaquine and artesunate-amodiaquine produced the most pronounced QT prolongation, while artemether-lumefantrine caused a smaller effect and pyronaridine-artesunate showed essentially none.18Scientific Reports. Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method
For travelers using prophylactic drugs, this cardiac concern is mostly relevant to chloroquine and mefloquine, particularly in people who are already taking other medications that prolong the QT interval (certain antidepressants, anti-nausea drugs, and some antibiotics). If you are on any daily medication, your prescriber should check for QT-prolonging interactions before starting malaria prophylaxis.
Quinine and Hearing
Quinine is an older antimalarial still used to treat severe or complicated malaria cases. Its best-known cluster of side effects is called cinchonism: tinnitus (ringing in the ears), headache, nausea, and blurred vision. The hearing component is real and measurable. A clinical study found that quinine reduced high-frequency hearing in all patients tested, flattening the normal shape of their hearing curves. The effect was rapid in onset and usually went unnoticed by the patients themselves, though several did report tinnitus.19PubMed Central. Quinine induces reversible high-tone hearing loss
The reassuring part is that quinine-induced hearing loss is reversible, resolving completely after treatment ends.20PubMed. Concentration-Response Relationship of Hearing Impairment Caused by Quinine and Salicylate: Pharmacological Similarities but Different Molecular Mechanisms The less reassuring part is that quinine has a narrow therapeutic window: the dose needed to kill malaria parasites sits uncomfortably close to the dose that produces toxicity. Quinine is administered in hospital settings under supervision specifically because of this.
Pregnancy and Children
Not all antimalarials are safe for pregnant women. Doxycycline is contraindicated in pregnancy because tetracycline-class drugs can harm fetal bone and tooth development. Primaquine is also off-limits during pregnancy due to the risk of hemolysis in a fetus whose G6PD status is unknown.21PubMed Central. Prophylactic use of antimalarials during pregnancy
Chloroquine and hydroxychloroquine are considered safe in all trimesters. Mefloquine is the preferred option for chloroquine-resistant areas and is not associated with increased risk to the fetus based on available evidence. Atovaquone-proguanil is not officially recommended during pregnancy due to limited data, though the evidence so far has not shown a clear pattern of harm.22PubMed Central. Safety of atovaquone-proguanil during pregnancy
In children, the same drugs are generally used at weight-adjusted doses, with a few extra considerations. A study of children on malaria prophylaxis found that about 12% of those taking antimalarials reported side effects. Among children on mefloquine, about 10% had problems including diarrhea, vivid dreams, headache, appetite loss, and, in two cases, hallucinations severe enough to prompt medical attention and drug discontinuation. Children on chloroquine reported headache, nausea, and sleep changes at a rate of about 23%.23PubMed. Side effects of and compliance with malaria prophylaxis in children Liquid formulations of chloroquine are notoriously bitter, which creates a practical barrier to compliance in young children.
Long-Term Use and the Compliance Problem
Many of the fears around malaria pills center on long-term safety, and those fears have real consequences. Among British expatriates taking long-term malaria prophylaxis, roughly 40% reported significant side effects, and more than half of those who dropped their compliance below 25% cited concerns about long-term safety as the reason.24PubMed. Compliance with long-term malaria prophylaxis in British expatriates The irony is that poor compliance with malaria pills is itself a health risk: malaria kills hundreds of thousands of people each year, and a half-taken prophylaxis course offers little protection.
A large study of returned Peace Corps Volunteers who used malaria prophylaxis for extended assignments between 1995 and 2014 found that long-term use was safe overall. The main actionable finding was the same one that keeps recurring: screening out people with prior psychiatric illness before prescribing mefloquine reduced psychiatric side effects.8PubMed Central. Long term health outcomes among Returned Peace Corps Volunteers after malaria prophylaxis, 1995-2014 For drugs like doxycycline, long-term use can increase the risk of vaginal yeast infections and may alter gut flora, but these are generally manageable. Atovaquone-proguanil is less studied for very long durations because it was initially approved only for shorter trips, though extended use has become more common in practice.
Rare but Severe Skin Reactions
Severe cutaneous adverse reactions, including conditions like Stevens-Johnson syndrome and toxic epidermal necrolysis, have been linked to certain antimalarials, though they are rare. An international scoping review identified sulfadoxine-pyrimethamine, an antimalarial combination still used in parts of Africa, as a culprit drug in severe skin reactions.25World Allergy Organization Journal. An international scoping review of epidemiologic studies on severe cutaneous adverse reactions Hydroxychloroquine was also flagged in studies from the Asia-Pacific region. These reactions involve widespread skin detachment and are medical emergencies, but they affect a very small fraction of users. Their existence is a reminder that any drug reaction involving a spreading rash, blistering, or peeling skin warrants immediate medical attention, not a wait-and-see approach.
Milder drug rashes and itching are more common, especially with chloroquine. In people of African descent, chloroquine-induced itching is a well-recognized phenomenon that can be severe enough to make the drug intolerable, even though it is not medically dangerous. This is another reason why one-size-fits-all antimalarial prescribing does not work; the choice of drug should account for individual risk factors, destination, and tolerance.